EUCTR2005-000040-85-DE进行中（未招募）不适用
Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom - Cetuximab Monotherapie beim HCC
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •advanced disease not amandable to regional therapies
- •metastatic disease
- •measurable disease
- •adequate hematological, renal and hepatic function
- •written informed consent
- •ECOG peformance status 2 or less
- •Life expectancy at least 3 months
- •failure of regional therapy at least 6 weeks prior to study treatment
- •adequate contraception
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •second malignancy within prior 5 years (exept basalioma, Cis of Cervix uteri)
- •severe medical condition
- •gravidity or lactation
- •thrombosis or severe bleeding within 6 months prior to study inclusion
- •major sugery within 4 weeks prior to study treatment
- •protracted wound heeling or ulcus
- •prior anti-tumor therapy less than 4 weeks prior to study treatment
研究者
相似试验
进行中（未招募）
不适用
FLOX + Erbitux. 1. line treatment to patients with metastatic colorectal cancer and wild type K-RAS tumor. A phase II study. - Nordic 7.5EUCTR2007-007834-21-DKOdense University Hospital86
进行中（未招募）
不适用
Epirubicin to patients with colorectal cancerEUCTR2013-001648-79-DKOdense University Hospital25
已完成
不适用
Efficacy of Eribulin Monotherapy in Patients with Unresectable Angiosarcoma--A Multicenter Prospective Observational StudyAngiosarcomaJPRN-UMIN000023331niversity of Tsukuba30
招募中
3 期
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.2024-518316-39-00Medical University Of Lodz25
已完成
不适用
A poilot study of eribulin monotherapy in chemorefractory patients with BRAF V600E-mutant metastatic colorectal cancercolorectal cancerJPRN-UMIN000027648Aichi Cancer Center Hospital5